You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Turkey sees sharp rise in obesity
- 2. ASCO 2025: Risk of fourteen obesity-related cancers for people with diabetes
- 3. Biden says he's 'feeling good' in first remarks after cancer diagnosis
- 4. Biden Somehow Says ‘I Don't Have Any Regrets' About Running for Reelection
- 5. ASCO 2025: Trial shows biomarkers hold clue in treating aggressive prostate cancer
- 6. Clinical Trials Demonstrate Monitoring PD-L1 Upregulation Using LifeTracDx Blood Test Could Support New Treatment Path for Metastatic Triple Negative Breast Cancer
- 7. ASCO 2025: Menopause drug duavee may help prevent invasive breast cancer
- 8. New IMV Study Reveals Key Trends in U.S. Breast Imaging: Procedure Growth, Equipment Plans, and Patient Priorities
- 9. Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
- 10. New three-drug combination 'could help women with aggressive breast cancer live longer'
Last updated at 13:09 GMT
Hot News Makers
Health/Pharma Companies
- 14535.11
- 4463.99
- 2495.58
- 1762.97
- 1687.95
- 1616.75
- 1300.55
- 1265.96
- 1146.71
- 1136.47
Drugs, Treatments, Trials
- 6784.40
- 3374.05
- 2626.36
- 1798.91
- 793.34
- 779.70
- 698.14
- 646.42
- 623.34
- 591.19
Last updated at 12:10 GMT
